A Trial Of Azithromycin SR For The Treatment Of Mild To Moderate Community Acquired Pneumonia In Japanese Adults

PHASE3CompletedINTERVENTIONAL
Enrollment

153

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

May 31, 2007

Study Completion Date

May 31, 2007

Conditions
Pneumonia, Community-Acquired
Interventions
DRUG

Azithromycin SR

Trial Locations (54)

289-2511

Pfizer Investigational Site, Asahi

810-0053

Pfizer Investigational Site, Fukuoka

813-0031

Pfizer Investigational Site, Fukuoka

813-0034

Pfizer Investigational Site, Fukuoka

812-0053

Pfizer Investigational Site, Higashi

811-2122

Pfizer Investigational Site, Kasuya-gun

811-3431

Pfizer Investigational Site, Munakata

819-8555

Pfizer Investigational Site, Nishiku

372-0817

Pfizer Investigational Site, Isesaki

371-0014

Pfizer Investigational Site, Maebashi

070-0038

Pfizer Investigational Site, Asahikawa

070-8012

Pfizer Investigational Site, Asahikawa

071-8133

Pfizer Investigational Site, Asahikawa

078-8261

Pfizer Investigational Site, Asahikawa

071-1521

Pfizer Investigational Site, Kamikawa-gun

004-0022

Pfizer Investigational Site, Sapporo

006-0032

Pfizer Investigational Site, Teine

317-0077

Pfizer Investigational Site, Hitachi

312-0057

Pfizer Investigational Site, Hitachi-Naka

309-1793

Pfizer Investigational Site, Kasama

302-0118

Pfizer Investigational Site, Moriya

302-0005

Pfizer Investigational Site, Toride

300-0053

Pfizer Investigational Site, Tsuchiura

763-0013

Pfizer Investigational Site, Marugame

232-0021

Pfizer Investigational Site, Yokohama

239-0821

Pfizer Investigational Site, Yokosuka

859-6131

Pfizer Investigational Site, Emukae, Kitamatsuura

857-8511

Pfizer Investigational Site, Hirase-cho, Sasebo,

852-8501

Pfizer Investigational Site, Nagasaki

852-8511

Pfizer Investigational Site, Shigesato-cho, Nagasaki

870-0022

Pfizer Investigational Site, Ohte-machi, Oita City

870-0161

Pfizer Investigational Site, Oita City, Oita

870-0263

Pfizer Investigational Site, Ōita

870-0921

Pfizer Investigational Site, Ōita

870-8511

Pfizer Investigational Site, Ōita

870-0852

Pfizer Investigational Site, Tanaka-machi, Oita

879-5593

Pfizer Investigational Site, Yufu

901-0152

Pfizer Investigational Site, Naha

903-0215

Pfizer Investigational Site, Nakagami-gun

904-2195

Pfizer Investigational Site, Okinawa

901-1303

Pfizer Investigational Site, Shimajiri-gun

574-0014

Pfizer Investigational Site, Daitō

576-0016

Pfizer Investigational Site, Katano

530-0004

Pfizer Investigational Site, Kita-ku

343-0807

Pfizer Investigational Site, Koshigaya

204-0022

Pfizer Investigational Site, Kiyose

164-0012

Pfizer Investigational Site, Nakano City

198-0021

Pfizer Investigational Site, Ōme

157-0061

Pfizer Investigational Site, Setagaya City

158-0095

Pfizer Investigational Site, Setagaya City

140-0011

Pfizer Investigational Site, Shinagawa

131-0043

Pfizer Investigational Site, Sumida City

990-8545

Pfizer Investigational Site, Yamagata

992-0045

Pfizer Investigational Site, Yonezawa

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY